ORLANDO, Fla. — One year ago, a Chinese scientist stepped up to a podium at the American Society of Hematology (ASH) annual meeting and presented early results from a Chinese-developed CAR-T therapy for multiple myeloma. The patient responses to this CAR-T were among the highest ever reported, but the data, collected entirely from patients in Chinese hospitals — were met with skepticism from the standing-room crowd.

When the floor was opened for questions, several English-speaking scientists in the audience rose up, grabbed available microphones and cast doubt on the credibility and trustworthiness of the Chinese CAR-T data. The Chinese scientist, in halting English, struggled to respond. It was an uncomfortable scene, and not what you’d expect to see at a typically genteel cancer research meeting.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy